<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE words SYSTEM "markables.dtd">
<markables xmlns="www.eml.org/NameSpaces/parse">
<markable id="markable_10001" span="word_1..word_5" tag="(S1 (SBAR (WHADVP (WRB Where)) (S (NP (DT the) (JJ real) (NN money)) (VP (VBZ is)))))" mmax_level="parse" />
<markable id="markable_10002" span="word_6..word_24" tag="(S1 (S (PP (IN At) (ADJP (JJ present))) (, ,) (NP (NP (JJS most) (NNS applications)) (PP (IN for) (NP (NNS biochips)))) (VP (VBP are) (PP (IN in) (NP (NP (JJ academic) (NN research)) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ new) (NN pharmaceutical) (NNS drugs))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10003" span="word_25..word_31" tag="(S1 (S (NP (NP (NN Demand)) (PP (IN for) (NP (PRP them)))) (VP (VBZ is) (VP (VBG growing) (ADVP (RB rapidly)))) (. .)))" mmax_level="parse" />
<markable id="markable_10004" span="word_32..word_66" tag="(S1 (S (NP (NNP Johnsee) (NNP Lee)) (VP (VBZ says) (SBAR (IN that) (S (S (PP (VBG according) (PP (IN to) (NP (NNP US) (NML (NN market) (NN research)) (NNS estimates)))) (, ,) (NP (NP (DT the) (JJ worldwide) (JJ annual) (NN consumption)) (PP (IN of) (NP (NN microarray) (NNS chips)))) (VP (VBZ is) (ADVP (RB currently)) (NP (QP (RB around) (CD 250,000))))) (: ;) (S (PP (IN in) (NP (CD two) (NNS years))) (NP (DT this)) (VP (VBZ is) (VP (VBN expected) (S (VP (TO to) (VP (VB grow) (PP (IN to) (NP (QP (CD 1.2) (CD million))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10005" span="word_67..word_104" tag="(S1 (S (PP (VBN Based) (PP (IN on) (NP (NP (DT a) (NN market) (NN price)) (PP (IN per) (NP (NN chip))) (PP (IN of) (NP ($ US$) (CD 1,000)))))) (, ,) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (NP (DT the) (NN world) (NN market)) (PP (IN in) (NP (NNS biochips)))))) (VP (MD could) (VP (VB grow) (PP (PP (IN to) (NP (NP (QP ($ US$) (CD 1.2) (CD billion))) (PP (IN in) (NP (CD 2003))))) (, ,) (CC and) (PP (IN to) (NP (QP ($ US$) (CD 40) (CD billion))))) (PP (IN over) (NP (DT the) (JJ next) (NN decade))))) (. .)))" mmax_level="parse" />
<markable id="markable_10006" span="word_105..word_144" tag="(S1 (S (ADVP (RB Thus)) (NP (DT some) (NNS people)) (VP (VP (VBP have) (VP (VBN set) (NP (PRP$ their) (NNS sights)) (PP (IN on) (NP (DT the) (NN biochip) (NN market))))) (, ,) (CC and) (VP (VBP believe) (SBAR (IN that) (S (PP (VBG following) (NP (NP (NP (NNP Taiwan) (POS 's)) (NN success)) (PP (IN in) (NP (DT the) (NN semiconductor) (NN field))))) (, ,) (NP (DT the) (NN island)) (VP (MD could) (VP (VB go) (PRT (RP on)) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ major) (NN center)) (PP (IN for) (NP (NP (NN contract) (NN manufacture)) (PP (IN of) (NP (NNS biochips))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10007" span="word_145..word_173" tag="(S1 (S (VP (VB Be) (SBAR (IN that) (S (SBAR (IN as) (S (NP (PRP it)) (VP (MD may)))) (, ,) (NP (NP (DT the) (JJ small) (NN number)) (PP (IN of) (NP (NP (NN biochip) (NNS companies)) (VP (ADVP (RB so) (RB far)) (VBN established) (PP (IN in) (NP (NNP Taiwan))))))) (ADVP (RB still)) (VP (VBP find) (NP (PRP$ their) (NN market)) (PP (IN in) (NP (NP (JJ domestic) (NN research) (NNS establishments)) (CC and) (NP (NNS pharmaceuticals) (NNS manufacturers)))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10008" span="word_174..word_202" tag="(S1 (S (S (SBAR (IN Although) (S (NP (PRP they)) (VP (VBP are) (ADVP (RB also)) (ADVP (RB actively)) (VP (VBG developing) (NP (JJ overseas) (NNS markets)))))) (, ,) (SBAR (WHNP (WP what)) (S (VP (VBZ interests) (NP (PRP them)) (ADVP (RBS most))))) (VP (VBZ is) (RB not) (NP (NP (NNS biochips)) (PP (IN per) (NP (FW se)))))) (, ,) (CC nor) (SQ (VBP are) (NP (PRP they)) (ADJP (JJ content) (S (ADVP (RB merely)) (VP (TO to) (VP (VB be) (NP (NN contract) (NNS manufacturers))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10009" span="word_203..word_220" tag="(S1 (S (`` '') (S (NP (DT The) (NNS chips)) (VP (VBP are) (NP (RB only) (DT a) (NN tool)))) (, ,) (CC and) (S (NP (DT the) (JJ big) (NN money)) (VP (VBZ is) (RB not) (PP (IN in) (NP (NN chip) (NNS sales))))) (. .)))" mmax_level="parse" />
<markable id="markable_10010" span="word_221..word_229" tag="(S1 (S (SBAR (WHNP (WP What)) (S (VP (VBZ counts)))) (VP (VBZ is) (NP (NP (DT the) (NN R&amp;D)) (PP (IN behind) (NP (PRP them))))) (. .) ('' '')))" mmax_level="parse" />
<markable id="markable_10011" span="word_230..word_275" tag="(S1 (S (NP (NP (NNP Jerry) (NNP Huang)) (, ,) (NP (NP (JJ executive) (NN vice) (NN president)) (PP (IN of) (NP (NML (NNP U) (HYPH -) (NNP Vision)) (JJ Biotech)))) (, ,)) (VP (VBZ reveals) (SBAR (IN that) (S (NP (NP (NNP U) (HYPH -) (NNP Vision)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN set) (PRT (RP up)) (PP (IN in) (NP (NNP September) (CD 1999))))))) (, ,)) (VP (VBZ has) (VP (VBN signed) (NP (DT a) (NN contract)) (PP (IN with) (NP (NP (DT the) (NNP US) (NN company)) (NP (NNP Zen) (HYPH -) (NNP Bio)))) (S (VP (TO to) (ADVP (RB jointly)) (VP (VB develop) (NP (JJ human) (NML (JJ adipocyte) (NN cDNA) (NN microarray)) (NNS chips)))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10012" span="word_276..word_319" tag="(S1 (S (NP (NNP Huang)) (VP (VBZ states) (SBAR (WHNP (WDT that)) (S (NP (NN research)) (PP (IN in) (NP (JJ recent) (NNS years))) (VP (VBZ has) (VP (VBN revealed) (S (PP (IN that) (NP (NP (NNS adipocytes)) (SBAR (S (-LRB- -LRB-) (NP (NN fat) (NNS cells)) (-RRB- -RRB-) (VP (VP (VBP are) (NP (NP (JJ active) (NNS regulators)) (PP (IN of) (NP (NP (DT the) (NN energy) (NN balance)) (PP (IN in) (NP (DT the) (NN body))))))) (, ,) (CC and) (VP (VB play) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NNS disorders)) (PP (JJ such) (IN as) (NP (NP (NN obesity)) (, ,) (NP (NN diabetes)) (, ,) (NP (NN osteoporosis)) (CC and) (NP (JJ cardiovascular) (NN disease))))))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10013" span="word_320..word_343" tag="(S1 (S (ADVP (RB Thus)) (NP (PRP it)) (VP (VBZ is) (VP (VBN hoped) (SBAR (IN that) (S (NP (NP (NN research)) (PP (IN into) (NP (JJ human) (NNS adipocytes)))) (VP (MD can) (VP (VB help) (PP (IN in) (NP (NP (DT the) (NN search)) (PP (IN for) (NP (NP (NNS drugs)) (CC and) (NP (JJ other) (NNS therapies) (S (VP (TO to) (VP (VB treat) (NP (DT these) (NNS disorders)))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10014" span="word_344..word_384" tag="(S1 (S (ADVP (RB Apart) (PP (IN from) (NP (DT this)))) (, ,) (NP (NNP U) (HYPH -) (NNP Vision)) (VP (VBZ is) (ADVP (RB also)) (VP (VBG conducting) (NP (NP (DT a) (NML (CD one) (HYPH -) (NN year)) (NML (JJ bacterial) (NN genome)) (NN project)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ aims) (S (VP (TO to) (VP (VB map) (NP (NP (DT the) (NN genome)) (PP (IN of) (NP (DT a) (JJ certain) (ADJP (NN drug) (HYPH -) (JJ resistant)) (NN bacterium)))) (PP (IN as) (NP (NP (DT a) (NN basis)) (PP (IN for) (S (VP (VBG developing) (NP (JJ new) (NNS vaccines) (CC and) (NNS drugs)))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10015" span="word_385..word_386" tag="(S1 (NP (NN Drug) (NN development)))" mmax_level="parse" />
<markable id="markable_10016" span="word_387..word_428" tag="(S1 (S (NP (NP (NP (NNP Taiwan) (NNP Genome) (NNPS Sciences)) (-LRB- -LRB-) (NP (NNP TGS)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN set) (PRT (RP up)) (PP (IN in) (NP (NNP November) (CD 1999))) (PP (IN as) (NP (NP (DT a) (JJ joint) (NN venture)) (PP (IN by) (NP (NP (DT the) (NNP Uni-President) (NNPS Enterprises) (NNP Group)) (, ,) (NP (NNP Yuen) (NNP Foong) (NNP Yu)) (CC and) (NP (NNP Tuntex) (NNPS Groups)))))))))) (, ,)) (ADVP (RB only)) (VP (VBD entered) (NP (DT the) (NN biotechnology) (NN fray)) (PP (IN in) (NP (NP (NNP April)) (PP (IN of) (NP (DT this) (NN year)))))) (. .)))" mmax_level="parse" />
<markable id="markable_10017" span="word_429..word_464" tag="(S1 (S (S (NP (NN CEO) (NNP Andrew) (NNP Kuo)) (VP (VBZ says) (SBAR (S (NP (DT the) (NNS investors)) (VP (VBD came) (PP (IN to) (NP (DT the) (NN view) (SBAR (IN that) (S (NP (NNP Taiwan)) (VP (VBZ needs) (S (VP (TO to) (VP (VB develop) (NP (PRP$ its) (NN biotechnology) (NNS industries))))))))))))))) (, ,) (CC and) (S (ADVP (RB therefore)) (NP (PRP they)) (VP (VBD combined) (NP (PRP$ their) (NNS resources)) (S (VP (TO to) (VP (VB make) (NP (NP (DT a) (NML (JJ long) (HYPH -) (NN term)) (NN investment)) (PP (IN in) (NP (DT the) (NN field))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10018" span="word_465..word_492" tag="(S1 (S (NP (NP (NNP TGS) (POS 's)) (NN strategy)) (VP (VBZ is) (S (VP (VP (TO to) (VP (VB invest) (PP (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNP US) (NN genome) (NN research) (NNS companies))))))) (, ,) (CC and) (VP (TO to) (VP (VB sign) (NP (NP (NP (NML (NN technology) (NN transfer)) (NNS agreements)) (CC and) (NP (NN chip) (NN production) (NNS contracts))) (PP (IN with) (NP (PRP them))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10019" span="word_493..word_533" tag="(S1 (S (S (NP (NNP Kuo)) (VP (VBZ comments) (SBAR (IN that) (S (NP (NP (NN contract) (NN production)) (PP (IN of) (NP (NNS chips)))) (VP (VBZ is) (ADVP (RB merely)) (NP (NP (DT a) (NN service) (NN activity)) (CC and) (NP (NP (DT a) (NN source)) (PP (IN of) (NP (NN income))) (PP (IN for) (NP (DT the) (NN company)))))))))) (: -) (S (NP (NP (NNP TGS) (POS 's)) (JJ ultimate) (NN goal)) (VP (VBZ is) (PP (IN in) (S (VP (VBG doing) (NP (NN R&amp;D) (NN work)) (S (VP (TO to) (VP (VB identify) (NP (NN gene) (NNS sequences)) (PP (IN as) (NP (NP (NNS targets)) (PP (IN for) (S (VP (VBG developing) (NP (JJ new) (NNS drugs))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10020" span="word_534..word_572" tag="(S1 (S (NP (NNP Kuo)) (VP (VBZ states) (SBAR (SBAR (IN that) (S (PP (IN at) (ADJP (JJ present))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (VBN known) (NN target) (NNS sequences)) (PP (IN for) (NP (ADJP (NN disease) (HYPH -) (VBG treating)) (NNS drugs)))))) (VP (VBZ is) (NP (QP (RB only) (IN around) (CD 500)))))) (, ,) (CC but) (SBAR (IN as) (S (NP (DT the) (JJ human) (NN genome)) (VP (VBZ is) (VP (VBN mapped) (PRT (RP out)) (NP (NP (DT this) (NN number)) (SBAR (S (VP (MD can) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (ADVP (RB tenfold))))))))))))))))) (. .)))" mmax_level="parse" />
<markable id="markable_10021" span="word_573..word_599" tag="(S1 (S (ADVP (RB Currently)) (, ,) (NP (NNP TGS)) (VP (VBZ has) (NP (NP (PRP$ its) (NNS sights)) (VP (VBN set) (PP (ADVP (RB mainly)) (IN on) (S (VP (VBG doing) (NP (NP (NN research)) (PP (IN into) (NP (NP (NNS diseases)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (RB especially) (JJ prevalent) (PP (IN in) (NP (NNP Asia))))))) (, ,) (PP (JJ such) (IN as) (NP (NML (NN liver) (CC and) (NN stomach)) (NNS cancers)))))))))))) (. .)))" mmax_level="parse" />
</markables>
